Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 42

Sort by

Sort Order Select

Journal Articles

Oncostatin M Is a Novel Niche Factor That Restrains Hematopoietic Stem Cell Mobilization in Response to G-CSF and CXCR4 Antagonist Plerixafor

Kavita Bisht, PhD, Crystal McGirr, Kylie A Alexander, Whitney Fleming, Natalie Sims, Gerhard Müller- Newen, Ingrid G Winkler, PhD, Jean-Pierre Levesque, PhD

Blood (2019) 134 (Supplement_1): 4469.

https://doi.org/10.1182/blood-2019-127431

Published: 2019

Journal Articles

Long Term Responses to Venetoclax and Ibrutinib in Mantle Cell Lymphoma Are Associated with Immunological Recovery and Prognostic Changes in Inflammatory Biomarkers

Joanne Davis, PhD, Sasanka M Handunnetti, MBBS, Chia Sharpe, Gillian Turner, Mary Ann Anderson, MBBS, PhD FRACP, FRCPA, Andrew W. Roberts, MBBS, PhD, John F. Seymour, MBBS, PhD FRACP, Constantine S. Tam, MBBS, MD, David Ritchie, MD PhD, Rachel Koldej

Blood (2019) 134 (Supplement_1): 2791.

https://doi.org/10.1182/blood-2019-122974

Published: 2019

Journal Articles

A Phase 1 Study of ALX148, a CD47 Blocker, in Combination with Rituximab in Patients with Non-Hodgkin Lymphoma

Tae Min Kim, MD PhD, Nehal Lakhani, MD PhD, Justin Gainor, MD, Manali Kamdar, MD MD, Philip Fanning, PhD, Pierre Squifflet, MSc, Feng Jin, PhD, Hong Wan, PhD, Jaume Pons, PhD, Sophia S Randolph, MD PhD, Won Seog Kim, MD PhD

Blood (2019) 134 (Supplement_1): 1953.

https://doi.org/10.1182/blood-2019-123219

Published: 2019

Journal Articles

Phase 2 Study of Efgartigimod, a Novel FcRn Antagonist, in Adult Patients with Primary Immune Thrombocytopenia

Adrian C. Newland, Blanca Sánchez-González, László Rejtő, Miklos Egyed, Nataliya Romanyuk, Marie Godar, Katrien Verschueren, Domenica Gandini, Peter Ulrichts, Jon Beauchamp, Torsten Dreier, E. Sally Ward, Marc Michel, Howard A. Liebman, Hans De Haard, Nicolas Leupin, David J. Kuter

Blood (2019) 134 (Supplement_1): 895.

https://doi.org/10.1182/blood-2019-128022

Published: 2019

Journal Articles

Cleavage of Anti-PF4/H IgG Antibodies By Ides, and Potential Benefit in the Treatment of Heparin-Induced Thrombocytopenia

Claire Kizlik-Masson, Quentin Deveuve, Yuhang Zhou, MD PhD, Caroline Vayne, PharmD, Gilles Thibault, PharmD, PhD, Steven Edward McKenzie, MD PhD, Claire Pouplard, PharmD, PhD, Stéphane Loyau, Jérôme Rollin, PhD, Yves Gruel, MD PhD

Blood (2018) 132 (Supplement 1): 518.

https://doi.org/10.1182/blood-2018-99-114450

Published: 2018

Journal Articles

ACTR087, Autologous T Lymphocytes Expressing Antibody Coupled T-Cell Receptors (ACTR), Induces Complete Responses in Patients with Relapsed or Refractory CD20-Positive B-Cell Lymphoma, in Combination with Rituximab

Luke Paul Akard, MD, Samantha Jaglowski, MD, Steven M. Devine, MD, Matthew S. McKinney, MD, Michael Vasconcelles, MD, Heather Huet, PhD, Seth Ettenberg, PhD, Ann Ranger, PhD, Jeremy S. Abramson, MD MMSc

Blood (2017)

https://doi.org/10.1182/blood.V130.Suppl_1.580.580

Published: 2017

Journal Articles

Pro-Inflammatory State of MGUS and Myeloma Patients Presenting with a Monoclonal Immunoglobulin Specific for an Infectious Pathogen

Adrien Bosseboeuf, PhD, Delphine Feron, PhD, Sophie Allain-Maillet, Nicolas Mennesson, Cathy Charlier, PhD, Anne Tallet, Francois Girodon, MD PhD, Laurent Garderet, MD PhD, Cédric Rossi, MD, Denis Caillot, MD, Philippe Moreau, MDPhD, Pierre Weigel, PhD, Eric Piver, PhD, Edith Bigot-Corbel, PhD, Jean Harb, PhD, Sylvie Hermouet, MDPhD

Blood (2017) 130 (Supplement 1): 3048.

https://doi.org/10.1182/blood.V130.Suppl_1.3048.3048

Published: 2017

Journal Articles

Genetic Fusion to Factor XIII B-Subunit Improves the Pharmacokinetic Properties of Factor IX

Sandra Le Quellec, MD, Nathalie Enjolras, PhD, Jean-Claude Bordet, Vladmir Jacqueline, Claude Negrier, MD, Yesim Dargaud, MD PhD

Blood (2017) 130 (Supplement 1): 2339.

https://doi.org/10.1182/blood.V130.Suppl_1.2339.2339

Published: 2017

Journal Articles

Characterization of 5B9, a Chimeric Monoclonal Anti-PF4/H Antibody with a Human Fc Fragment and Which Mimics the Effects of HIT Human Antibodies

Jérome Rollin, PhD, Claire Kizlik-Masson, Steven McKenzie, MD PhD, Anne Poupon, PhD, Yuhang Zhou, MD, Caroline Vayne, Gaël Champier, PhD, Claire Pouplard, Pharm D, PhD, Yves Gruel, MD

Blood (2016) 128 (22): 138.

https://doi.org/10.1182/blood.V128.22.138.138

Published: 2016

Journal Articles

Combination Therapy with Daratumumab and CAR-NK Targeting CS1 for Multiple Myeloma

Yibo Zhang, PhD, Lichao Chen, Yufeng Wang, Xinxin Li, Tiffany Hughes, Hans Klingemann, Don M Benson, MD PhD, Jianhua Yu, PhD

Blood (2016) 128 (22): 1342.

https://doi.org/10.1182/blood.V128.22.1342.1342

Published: 2016

Journal Articles

Intravenous Immunoglobulin (IVIg) Is a Highly Effective Treatment for HIT: Critical Role of the IgG Fc Domain in Inhibiting HIT Antibody-Mediated Platelet Activation

Anand Padmanabhan, MBBS, MA, PhD, Curtis G Jones, Shannon M Pechauer, Barbara J. Bryant, MD, Jack B. Alperin, MD, Mehraboon S. Irani, MBBChir, Binod Dhakal, MDMS, Brian R Curtis, PhD D(ABMLI) MT(ASCP)SBB, Daniel W. Bougie, PhD, Mia J Sullivan, Renren Wen, PhD, Demin Wang, PhD, Richard H. Aster, MD

Blood (2016) 128 (22): 2600.

https://doi.org/10.1182/blood.V128.22.2600.2600

Published: 2016

Journal Articles

Argx-113, a Novel Fc-Based Approach for Antibody-Induced Pathologies Such As Primary Immune Thrombocytopenia

Peter Ulrichts, PhD, Thierry Cousin, MD, Torsten Dreier, PhD, Hans de Haard, PhD, Nicolas Leupin, MD

Blood (2016) 128 (22): 4919.

https://doi.org/10.1182/blood.V128.22.4919.4919

Published: 2016

Journal Articles

CAR-Engineered T Cells Specific for the Elotuzumab Target SLAMF7 Eliminate Primary Myeloma Cells and Confer Selective Fratricide of SLAMF7+ Normal Lymphocyte Subsets

Sophia Danhof, MD, Tea Gogishvili, PhD, Silvia Koch, Martin Schreder, MD, Stefan Knop, Hermann Einsele, Michael Hudecek, MD

Blood (2015) 126 (23): 115.

https://doi.org/10.1182/blood.V126.23.115.115

Published: 2015

Journal Articles

SIRPαFc, a CD47-Blocking Cancer Immunotherapeutic, Sensitizes Malignant B Cells to Macrophage-Mediated Destruction

Natasja Nielsen Viller, Saman Maleki Vareki, Karen Dodge, Hui Chen, Vivian Lee, Vien Chai, Xinli Pang, Mark Wong, Suzanne Trudel, MD, Rene Figueredo, Macarena Pampillo, James Koropatnick, Penka S. Petrova, Robert A. Uger

Blood (2015) 126 (23): 2191.

https://doi.org/10.1182/blood.V126.23.2191.2191

Published: 2015

Journal Articles

Soluble Bcma in Myeloma Serum Binds Its Ligands BAFF and Prevents Normal Antibody Production in Multiple Myeloma Patients

Eric Sanchez, BA, Abigail Gillespie, BS, Nika Manik Harutyunyan, George Tang, PhD, Jillian Gottlieb, Suzie Vardanyan, MS, Mingjie Li, BS, Claudia Andreu-Vieyra, Michael Ghermezi, Cathy Wang, BS, Joseph Ben-Zvi, Gigi Garzio, Haiming Chen, MD PhD, James Berenson, MD

Blood (2015) 126 (23): 1799.

https://doi.org/10.1182/blood.V126.23.1799.1799

Published: 2015

Journal Articles

Circulating Bcma Binding to Its Ligand BAFF Prevents Normal Antibody Production in Multiple Myeloma Patients

Eric Sanchez, BA, Abigail Gillespie, Nika M Harutyunyan, George Tang, PhD, Jillian Gottlieb, Suzie Vardanyan, MS, Mingjie Li, BS, Claudia Andreu-Vieyra, Michael Ghermezi, Cathy Wang, BS, Joseph Ben-Zvi, Gigi Garzio, Judith Finlay, PhD, Benjamin Bonavida, PhD, Haiming Chen, MD, PhD, James R. Berenson, MD

Blood (2014) 124 (21): 4713.

https://doi.org/10.1182/blood.V124.21.4713.4713

Published: 2014

Journal Articles

B7H1/B7.1 Interaction Alleviate Acute Gvhd in a PD-1 Dependent Manner

Ruishu Deng, MDPhD, Kaniel Cassady, Xiaofan Li, MDPhD, Sheng Yao, PhD, Mingfeng Zhang, PhD, Jeremy Racine, PhD, Jeffrey Lin, Lieping Chen, MDPhD, Defu Zeng, MD

Blood (2014) 124 (21): 2423.

https://doi.org/10.1182/blood.V124.21.2423.2423

Published: 2014

Journal Articles

Peripheral blood monocyte-derived chemokine blockade prevents murine transfusion-related acute lung injury (TRALI)

Christopher G. J. McKenzie, Michael Kim, Tarandeep K. Singh, Youli Milev, John Freedman, John W. Semple

Blood (2014) 123 (22): 3496–3503.

https://doi.org/10.1182/blood-2013-11-536755

Published: 2014

Includes: Supplemental data

Journal Articles

B Cell Receptors Of Chlamydophila Psittaci negative MALT Lymphomas Of The Ocular Adnexa Recognize Common Self-Antigens

Daxing Zhu, MD, Xiaoqing Lu, M.D, Marcus Dühren-von Minden, M.Sc., Shruti Bhatt, MS, Chen Lossos, Jennifer R. Chapman-Fredricks, MD, Hendrik Veelken, MD PhD, Hassan Jumaa, PhD, Izidore S Lossos, MD

Blood (2013) 122 (21): 4266.

https://doi.org/10.1182/blood.V122.21.4266.4266

Published: 2013

Journal Articles

Genetic Variations In Immune Regulatory Genes and The Risk For Diffuse Large B-Cell Lymphoma

Jeong-Eun Kang, In-Suk Kim, MD, PhD, Nam-Hee Kim, Min Kyoung Kim

Blood (2013) 122 (21): 4286.

https://doi.org/10.1182/blood.V122.21.4286.4286

Published: 2013

NARROW

Oncostatin M Is a Novel Niche Factor That Restrains Hematopoietic Stem Cell Mobilization in Response to G-CSF and CXCR4 Antagonist Plerixafor

Long Term Responses to Venetoclax and Ibrutinib in Mantle Cell Lymphoma Are Associated with Immunological Recovery and Prognostic Changes in Inflammatory Biomarkers

A Phase 1 Study of ALX148, a CD47 Blocker, in Combination with Rituximab in Patients with Non-Hodgkin Lymphoma

Phase 2 Study of Efgartigimod, a Novel FcRn Antagonist, in Adult Patients with Primary Immune Thrombocytopenia

Cleavage of Anti-PF4/H IgG Antibodies By Ides, and Potential Benefit in the Treatment of Heparin-Induced Thrombocytopenia

ACTR087, Autologous T Lymphocytes Expressing Antibody Coupled T-Cell Receptors (ACTR), Induces Complete Responses in Patients with Relapsed or Refractory CD20-Positive B-Cell Lymphoma, in Combination with Rituximab

Pro-Inflammatory State of MGUS and Myeloma Patients Presenting with a Monoclonal Immunoglobulin Specific for an Infectious Pathogen

Genetic Fusion to Factor XIII B-Subunit Improves the Pharmacokinetic Properties of Factor IX

Characterization of 5B9, a Chimeric Monoclonal Anti-PF4/H Antibody with a Human Fc Fragment and Which Mimics the Effects of HIT Human Antibodies

Combination Therapy with Daratumumab and CAR-NK Targeting CS1 for Multiple Myeloma

Intravenous Immunoglobulin (IVIg) Is a Highly Effective Treatment for HIT: Critical Role of the IgG Fc Domain in Inhibiting HIT Antibody-Mediated Platelet Activation

Argx-113, a Novel Fc-Based Approach for Antibody-Induced Pathologies Such As Primary Immune Thrombocytopenia

CAR-Engineered T Cells Specific for the Elotuzumab Target SLAMF7 Eliminate Primary Myeloma Cells and Confer Selective Fratricide of SLAMF7+ Normal Lymphocyte Subsets

SIRPαFc, a CD47-Blocking Cancer Immunotherapeutic, Sensitizes Malignant B Cells to Macrophage-Mediated Destruction

Soluble Bcma in Myeloma Serum Binds Its Ligands BAFF and Prevents Normal Antibody Production in Multiple Myeloma Patients

Circulating Bcma Binding to Its Ligand BAFF Prevents Normal Antibody Production in Multiple Myeloma Patients

B7H1/B7.1 Interaction Alleviate Acute Gvhd in a PD-1 Dependent Manner

Peripheral blood monocyte-derived chemokine blockade prevents murine transfusion-related acute lung injury (TRALI)

B Cell Receptors Of Chlamydophila Psittaci negative MALT Lymphomas Of The Ocular Adnexa Recognize Common Self-Antigens

Genetic Variations In Immune Regulatory Genes and The Risk For Diffuse Large B-Cell Lymphoma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only